DeepMed Research

DENVER HEALTH AND HOSPITAL AUTHORITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The DETECT HCV Screening Trial

Not Applicable

Completed

Conditions: Hepatitis C

Interventions: Other: HCV Screening

First Posted Date: 2019-07-01

Last Posted Date: 2025-02-06

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 147533

Registration Number: NCT04003454

Locations: 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸
Denver Health Medical Center, Denver, Colorado, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Enhancing Cardiac Rehabilitation Through Behavioral Nudges

Not Applicable

Completed

Conditions: Coronary Artery Disease
Valvular Disease
Acute Myocardial Infarction
Percutaneous Coronary Intervention
Chronic Stable Angina
Chronic Stable Heart Failure

Interventions: Other: Hospital-based CR + Movn Application
Other: Choice of Hospital or home-based CR + Movn Application + Nudge
Other: Choice of Hospital or home-based CR + Movn Application
Other: Hospital-based CR + Movn Application + Nudge

First Posted Date: 2019-02-07

Last Posted Date: 2025-05-13

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 447

Registration Number: NCT03834155

Locations: 🇺🇸
Denver Health and Hospital Authority, Denver, Colorado, United States

Pupil Dilation for Treatment of IFIS

Phase 2

Completed

Conditions: Intraoperative Floppy Iris Syndrome

Interventions: Drug: Brimonidine Tartrate

First Posted Date: 2018-11-30

Last Posted Date: 2022-04-20

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 13

Registration Number: NCT03760185

Locations: 🇺🇸
Denver Health, Denver, Colorado, United States

Exploration of Pupil Dilation in Horner's Patients Taking Flomax

Phase 4

Terminated

Conditions: Horner Syndrome

Interventions: Drug: 10% phenylephrine

First Posted Date: 2018-08-03

Last Posted Date: 2022-03-03

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 1

Registration Number: NCT03615508

Locations: 🇺🇸
University of Colorado Hospital, Rocky Mountain Lions Eye Institute, Denver, Colorado, United States
🇺🇸
Denver Health, Denver, Colorado, United States

Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication

Not Applicable

Completed

Conditions: Coagulopathy
Empyema, Pleural
Parapneumonic Effusion

Interventions: Procedure: VATS Decortication
Drug: Fibrinolytic Therapy

First Posted Date: 2018-07-12

Last Posted Date: 2022-01-27

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 10

Registration Number: NCT03583931

Locations: 🇺🇸
Denver Health, Denver, Colorado, United States

Reporting Patient Generated Health Data and Patient Reported Outcomes With Health Information Technology

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: 16-week program
Behavioral: Patient generated health data

First Posted Date: 2017-12-29

Last Posted Date: 2022-09-26

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 300

Registration Number: NCT03386773

Locations: 🇺🇸
Denver Health and Hospital Authority, Denver, Colorado, United States

Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures

Phase 4

Completed

Conditions: Intercostal Rib
Drug Effect
Rib Trauma
Pain; Catheter (Other)
Nerve Pain
Anesthesia, Local
Surgical Procedure, Unspecified
Opioid Dependence
Chest Injury Trauma
Rib Fractures

Interventions: Drug: Bupivacaine indwelling catheter
Drug: Liposomal bupivacaine injection

First Posted Date: 2017-10-10

Last Posted Date: 2021-09-29

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 36

Registration Number: NCT03305666

Locations: 🇺🇸
Denver Health, Denver, Colorado, United States

Multicenter RCT of SSRF in Non Flail Patients

Not Applicable

Completed

Conditions: Rib Fracture Multiple

Interventions: Device: Operative

First Posted Date: 2017-07-18

Last Posted Date: 2021-05-06

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 110

Registration Number: NCT03221595

Locations: 🇺🇸
Denver Health Medical Center, Denver, Colorado, United States

APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors

Phase 4

Withdrawn

Conditions: Acetaminophen Exposure

Interventions: Drug: Acetaminophen

First Posted Date: 2016-09-23

Last Posted Date: 2021-09-02

Lead Sponsor: Denver Health and Hospital Authority

Registration Number: NCT02911961

Locations: 🇺🇸
University of Colorado Denver, Denver, Colorado, United States

STAT-STatin and Aspirin in Trauma

Phase 2

Terminated

Conditions: Wounds and Injuries
Venous Thromboembolism

Interventions: Drug: Aspirin and Rosuvastatin
Drug: Placebo (for Aspirin and Rosuvastatin)

First Posted Date: 2016-09-15

Last Posted Date: 2023-04-27

Lead Sponsor: Denver Health and Hospital Authority

Target Recruit Count: 43

Registration Number: NCT02901067

Locations: 🇺🇸
Denver Health Medical Center, Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy